Search for grants with us!
Grants you might be eligible for
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)
PAR-25-316
Programme: NIH Grants
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Funding
Up to 275000.00 USD
Eligible Participants
Deadline
Jan. 7, 2028, 10 p.m.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA-CA-25-001
Grant Overview
Eligibility Criteria
Up to 150000.00 USD
Oct. 3, 2025, 10 p.m.
New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
RFA-DK-26-009
Up to 100000.00 USD
March 6, 2026, 10 p.m.
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
PAR-24-330
Programme: National Institutes of Health (NIH)
Up to None USD
Sept. 7, 2027, 9 p.m.
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
RFA-HG-25-009
Up to 400000.00 USD
Feb. 26, 2027, 10 p.m.
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
PAR-25-330
Up to 500000.00 USD
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
RFA-DK-26-007
Up to 1200000.00 USD
March 8, 2026, 10 p.m.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
PAR-25-353
Programme: NIH Mental Health Research Grants
Oct. 25, 2027, 9 p.m.
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
PAR-25-318
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
PA-25-150
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
PA-25-280
May 7, 2028, 9 p.m.
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
PAR-25-099
Up to 225000.00 USD
Dec. 4, 2026, 10 p.m.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA-CA-25-002
Programme: Innovative Molecular Analysis Technologies (IMAT) Program
Up to 300000.00 USD
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-25-029
Programme: National Institutes of Health
Sept. 11, 2025, 10 p.m.
F25AS00165 Partners for Fish and Wildlife FY25
F25AS00165
Programme: Partners for Fish and Wildlife
Up to 750000.00 USD
Oct. 1, 2025, 3:59 a.m.
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
PAR-25-342
May 7, 2027, 9 p.m.
NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
RFA-DK-26-001
Programme: NIDDK
Up to 400.00 USD
June 10, 2025, 10 p.m.
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
PAR-24-300
Up to 450000.00 USD
May 7, 2025, 9 p.m.
Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)
PAR-25-312
Jan. 11, 2028, 10 p.m.
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR-25-141
March 4, 2027, 10 p.m.
789 results. Page 3 of 40.